Tao, L. V., Karasinska, J. M., Souza, V. G. P., Loree, J. M., Johnson, J. D., Renouf, D. J., & Schaeffer, D. F. (2026). New-onset diabetes as an emerging risk group for early detection of pancreatic cancer: Current evidence, clinical challenge, and future directions. Frontiers in Gastroenterology (Frontiers Media S.A.), 1. https://doi.org/10.3389/fgstr.2025.1645459
Chicago Style (17th ed.) CitationTao, Lan Valerie, Joanna M. Karasinska, Vanessa G. P. Souza, Jonathan M. Loree, James D. Johnson, Daniel J. Renouf, and David F. Schaeffer. "New-onset Diabetes as an Emerging Risk Group for Early Detection of Pancreatic Cancer: Current Evidence, Clinical Challenge, and Future Directions." Frontiers in Gastroenterology (Frontiers Media S.A.) 2026: 1. https://doi.org/10.3389/fgstr.2025.1645459.
MLA (9th ed.) CitationTao, Lan Valerie, et al. "New-onset Diabetes as an Emerging Risk Group for Early Detection of Pancreatic Cancer: Current Evidence, Clinical Challenge, and Future Directions." Frontiers in Gastroenterology (Frontiers Media S.A.), 2026, p. 1, https://doi.org/10.3389/fgstr.2025.1645459.